While the study clarifies some conflicting findings on NVAMD risk in adults taking GLP-1s for type 2 diabetes, Cai warns that her groups findings should not be applied to other groups, such as people taking GLP-1 drugs primarily for weight loss, and additional research should be done in people without type 2 diabetes
Jain J, Sharma P, Jain J, et al
Peak Wellness operates on a cash-pay model only
Weight Loss by Hims is a holistic program that includes nutrition support, technological tools, and medications prescribed based on what your provider determines is medically appropriate and necessary for you
The PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways and 49 peptides linked to GLP-1 response, including your GLP1R status, FTO appetite-regulation variants (rs9939609), and GIPR glucose-dependent signaling markers